Assessment of Metabolic Scores for Visceral Fat and the Risk of Cardiovascular Disease in Adults with Stages 0–3 of CKM Syndrome: Findings from a Longitudinal CHARLS Study - Report - MDSpire
Advertisement
Assessment of Metabolic Scores for Visceral Fat and the Risk of Cardiovascular Disease in Adults with Stages 0–3 of CKM Syndrome: Findings from a Longitudinal CHARLS Study
Assessment of Metabolic Scores for Visceral Fat and CVD Risk in CKM Syndrome
Overview
This study investigates the relationship between the Metabolic Score for Visceral Fat (METS-VF) and cardiovascular disease (CVD) risk in adults with stages 0-3 of Cardiovascular-Kidney-Metabolic (CKM) syndrome. It highlights the mediating role of insulin sensitivity, as measured by estimated glucose disposal rate (eGDR), in this relationship.
Background
CKM syndrome is a growing global health concern characterized by the interplay of cardiovascular disease, chronic kidney disease, and metabolic dysfunction. The risk of CVD escalates with the progression of CKM syndrome stages, underscoring the need for effective risk stratification tools. Current clinical indicators are inadequate for predicting CVD progression in CKM syndrome, necessitating innovative approaches like METS-VF.
Data Highlights
No numerical data available in the provided text.
Key Findings
METS-VF integrates multiple factors, including METS-IR and waist-to-height ratio, providing a robust measure of cardiometabolic risk.
Insulin resistance is a key factor linking visceral fat and CVD development in CKM syndrome.
The study utilized data from the CHARLS cohort, which includes a diverse population across China.
METS-VF may improve risk stratification for CVD in CKM syndrome compared to traditional metrics.
eGDR mediates the relationship between METS-VF and CVD risk, highlighting the importance of insulin sensitivity.
Clinical Implications
Healthcare professionals should consider the use of METS-VF as a more accurate tool for assessing CVD risk in patients with CKM syndrome. Understanding the role of insulin sensitivity in this context may guide targeted interventions to mitigate cardiovascular risks.
Conclusion
The findings suggest that METS-VF is a valuable index for predicting CVD risk in CKM syndrome, with insulin sensitivity playing a crucial mediating role. Further research is warranted to validate these findings and enhance clinical practice.
